Skip to main content
Top

Open Access 25-04-2024 | Positron Emission Tomography | Oncology

Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation

Authors: Montserrat Carles, Dejan Kuhn, Tobias Fechter, Dimos Baltas, Michael Mix, Ursula Nestle, Anca L. Grosu, Luis Martí-Bonmatí, Gianluca Radicioni, Eleni Gkika

Published in: European Radiology

Login to get access

Abstract

Objectives

In lung cancer, one of the main limitations for the optimal integration of the biological and anatomical information derived from Positron Emission Tomography (PET) and Computed Tomography (CT) is the time and expertise required for the evaluation of the different respiratory phases. In this study, we present two open-source models able to automatically segment lung tumors on PET and CT, with and without motion compensation.

Materials and methods

This study involved time-bin gated (4D) and non-gated (3D) PET/CT images from two prospective lung cancer cohorts (Trials 108237 and 108472) and one retrospective. For model construction, the ground truth (GT) was defined by consensus of two experts, and the nnU-Net with 5-fold cross-validation was applied to 560 4D-images for PET and 100 3D-images for CT. The test sets included 270 4D- images and 19 3D-images for PET and 80 4D-images and 27 3D-images for CT, recruited at 10 different centres.

Results

In the performance evaluation with the multicentre test sets, the Dice Similarity Coefficients (DSC) obtained for our PET model were DSC(4D-PET) = 0.74 ± 0.06, improving 19% relative to the DSC between experts and DSC(3D-PET) = 0.82 ± 0.11. The performance for CT was DSC(4D-CT) = 0.61 ± 0.28 and DSC(3D-CT) = 0.63 ± 0.34, improving 4% and 15% relative to DSC between experts.

Conclusions

Performance evaluation demonstrated that the automatic segmentation models have the potential to achieve accuracy comparable to manual segmentation and thus hold promise for clinical application. The resulting models can be freely downloaded and employed to support the integration of 3D- or 4D- PET/CT and to facilitate the evaluation of its impact on lung cancer clinical practice.

Clinical relevance statement

We provide two open-source nnU-Net models for the automatic segmentation of lung tumors on PET/CT to facilitate the optimal integration of biological and anatomical information in clinical practice. The models have superior performance compared to the variability observed in manual segmentations by the different experts for images with and without motion compensation, allowing to take advantage in the clinical practice of the more accurate and robust 4D-quantification.

Key Points

  • Lung tumor segmentation on PET/CT imaging is limited by respiratory motion and manual delineation is time consuming and suffer from inter- and intra-variability.
  • Our segmentation models had superior performance compared to the manual segmentations by different experts.
  • Automating PET image segmentation allows for easier clinical implementation of biological information.
Literature
3.
go back to reference UyBico SJ, Wu CC, Suh RD, Le NH, Brown K, Krishnam MS (2010) Lung cancer staging essentials: the new tnm staging system and potential imaging pitfalls. Radiographics 30:1163–1181CrossRefPubMed UyBico SJ, Wu CC, Suh RD, Le NH, Brown K, Krishnam MS (2010) Lung cancer staging essentials: the new tnm staging system and potential imaging pitfalls. Radiographics 30:1163–1181CrossRefPubMed
4.
go back to reference Pommier P, Touboul E, Chabaud S et al (2010) Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: a prospective multicenter study. AJR Am J Roentgenol 195:350–355CrossRefPubMed Pommier P, Touboul E, Chabaud S et al (2010) Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: a prospective multicenter study. AJR Am J Roentgenol 195:350–355CrossRefPubMed
5.
go back to reference Postmus PE, Kerr KM, Oudkerk M et al (2017) Early and locally advanced non-small-cell lung cancer (nsclc): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv1–iv21CrossRefPubMed Postmus PE, Kerr KM, Oudkerk M et al (2017) Early and locally advanced non-small-cell lung cancer (nsclc): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv1–iv21CrossRefPubMed
8.
go back to reference Kong F, Hu C, Machta M et al (2021) OA02.04 randomized phase II trial (RTOG1106) on midtreatment PET/CT guided adaptive radiotherapy in locally advanced non-small cell lung cancer. J Thoracic Oncol 16:S104–S105CrossRef Kong F, Hu C, Machta M et al (2021) OA02.04 randomized phase II trial (RTOG1106) on midtreatment PET/CT guided adaptive radiotherapy in locally advanced non-small cell lung cancer. J Thoracic Oncol 16:S104–S105CrossRef
9.
go back to reference Vinod SK, Hau E (2020) Radiotherapy treatment for lung cancer: current status and future directions. Respirology 25:61–71CrossRefPubMed Vinod SK, Hau E (2020) Radiotherapy treatment for lung cancer: current status and future directions. Respirology 25:61–71CrossRefPubMed
10.
go back to reference Nestle U, Schimek-Jasch T, Kremp S et al (2020) Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-plan): a multicentre, open-label, randomised, controlled trial. Lancet Oncol 21:581–592CrossRefPubMed Nestle U, Schimek-Jasch T, Kremp S et al (2020) Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-plan): a multicentre, open-label, randomised, controlled trial. Lancet Oncol 21:581–592CrossRefPubMed
12.
go back to reference Gkika E, Grosu AL, Nestle U (2023) The use of 18 F-FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini-review. Precision Cancer Med 6:1–7.CrossRef Gkika E, Grosu AL, Nestle U (2023) The use of 18 F-FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini-review. Precision Cancer Med 6:1–7.CrossRef
14.
go back to reference Büther F, Vehren T, Schäfers KP, Schäfers M (2016) Impact of data-driven respiratory gating in clinical PET. Radiology 281:229–238CrossRefPubMed Büther F, Vehren T, Schäfers KP, Schäfers M (2016) Impact of data-driven respiratory gating in clinical PET. Radiology 281:229–238CrossRefPubMed
16.
go back to reference Chang G, Chang T, Pan T, Clark JW, Mawlawi OR (2010) Joint correction of respiratory motion artifact and partial volume effect in lung/thoracic PET/CT imaging. Med Phys 37:6221–6232CrossRefPubMedPubMedCentral Chang G, Chang T, Pan T, Clark JW, Mawlawi OR (2010) Joint correction of respiratory motion artifact and partial volume effect in lung/thoracic PET/CT imaging. Med Phys 37:6221–6232CrossRefPubMedPubMedCentral
17.
go back to reference Dawood M, Büther F, Lang N, Schober O, Schäfers KP (2007) Respiratory gating in positron emission tomography: a quantitative comparison of different gating schemes. Med Phys 34:3067–3076CrossRefPubMed Dawood M, Büther F, Lang N, Schober O, Schäfers KP (2007) Respiratory gating in positron emission tomography: a quantitative comparison of different gating schemes. Med Phys 34:3067–3076CrossRefPubMed
18.
go back to reference Nehmeh SA, Erdi YE, Rosenzweig KE et al (2003) Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET. J Nucl Med 44:1644–1648PubMed Nehmeh SA, Erdi YE, Rosenzweig KE et al (2003) Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET. J Nucl Med 44:1644–1648PubMed
19.
go back to reference Park SJ, Ionascu D, Killoran JJ et al (2008) Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images. Phys Med Biol 53:3661–3679CrossRefPubMed Park SJ, Ionascu D, Killoran JJ et al (2008) Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images. Phys Med Biol 53:3661–3679CrossRefPubMed
20.
go back to reference Chirindel A, Adebahr S, Schuster D et al (2015) Impact of 4D- 18FDG- PET/CT imaging on target volume delineation in SBRT patients with central versus peripheral lung tumors. Multi-reader comparative study. Radiother Oncol 115:335–341CrossRefPubMed Chirindel A, Adebahr S, Schuster D et al (2015) Impact of 4D- 18FDG- PET/CT imaging on target volume delineation in SBRT patients with central versus peripheral lung tumors. Multi-reader comparative study. Radiother Oncol 115:335–341CrossRefPubMed
23.
go back to reference Carles M, Torres-Espallardo I, Alberich-Bayarri A et al (2016) Evaluation of PET texture features with heterogeneous phantoms: complementarity and effect of motion and segmentation method. Phys Med Biol 62:652–9251CrossRefPubMed Carles M, Torres-Espallardo I, Alberich-Bayarri A et al (2016) Evaluation of PET texture features with heterogeneous phantoms: complementarity and effect of motion and segmentation method. Phys Med Biol 62:652–9251CrossRefPubMed
24.
go back to reference Carles M, Bach T, Torres-Espallardo I, Baltas D, Nestle U, Martí-Bonmatí L (2018) Significance of the impact of motion compensation on the variability of pet image features. Phys Med Biol 63:065013CrossRefPubMed Carles M, Bach T, Torres-Espallardo I, Baltas D, Nestle U, Martí-Bonmatí L (2018) Significance of the impact of motion compensation on the variability of pet image features. Phys Med Biol 63:065013CrossRefPubMed
28.
go back to reference Litjens G, Kooi T, Bejnordi BE et al (2017) A survey on deep learning in medical image analysis. Med Image Anal 42:60–88CrossRefPubMed Litjens G, Kooi T, Bejnordi BE et al (2017) A survey on deep learning in medical image analysis. Med Image Anal 42:60–88CrossRefPubMed
33.
go back to reference Nestle U, Adebahr S, Kaier K et al (2020) Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): results of the phase II STRIPE trial. Radiother Oncol 148:82–88CrossRefPubMed Nestle U, Adebahr S, Kaier K et al (2020) Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): results of the phase II STRIPE trial. Radiother Oncol 148:82–88CrossRefPubMed
38.
go back to reference Zou KH, Warfield SK, Bharatha A et al (2004) Statistical validation of image segmentation quality based on a spatial overlap index. Acad Radiol 11:178–189CrossRefPubMedPubMedCentral Zou KH, Warfield SK, Bharatha A et al (2004) Statistical validation of image segmentation quality based on a spatial overlap index. Acad Radiol 11:178–189CrossRefPubMedPubMedCentral
Metadata
Title
Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation
Authors
Montserrat Carles
Dejan Kuhn
Tobias Fechter
Dimos Baltas
Michael Mix
Ursula Nestle
Anca L. Grosu
Luis Martí-Bonmatí
Gianluca Radicioni
Eleni Gkika
Publication date
25-04-2024
Publisher
Springer Berlin Heidelberg
Published in
European Radiology
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-024-10751-2